FDA Drug recall D-0166-2021
Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462…
- FDA Drug
- Class I
- terminated
- Published 2020-12-09
On 2020-12-09 the FDA classified a Class I recall of Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462… by Torrent Pharma, citing failed Dissolution Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0166-2021 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2020-11-25 |
| Published | 2020-12-09 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Torrent Pharma |
| Distribution | US |
Product
Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01
Reason
Failed Dissolution Specifications
Identifiers
| ndc | 13668-453-30 |
|---|---|
| ndc | 13668-453-01 |
| ndc | 13668-462-30 |
| ndc | 13668-462-01 |
| code_info | Batch BFD1G001, exp 12/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0166-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.